Generating real-world evidence (RWE) is increasingly important for pharmaceutical development, post-marketing studies, and regulatory submissions. Collecting high-quality, reliable data from diverse sources such as electronic health records, patient registries, and observational studies requires robust RWE data capture software. Traditional clinical trial platforms often focus on controlled trials and lack the flexibility to handle real-world data efficiently. Early adoption of an integrated platform designed for real-world evidence studies can save time, reduce errors, and improve data integrity.

RWE studies differ from traditional clinical trials because they capture patient outcomes in routine practice rather than controlled experimental conditions. This requires flexible data capture systems that can handle varied data sources, multiple study sites, and ongoing longitudinal tracking. Enterprise EDC systems like Medidata Rave or Veeva are comprehensive but often too rigid and costly for RWE studies. Teams may face long onboarding timelines, technical complexity, and high vendor fees, making them impractical for observational or registry-based research.

Open-source solutions such as REDCap provide a low-cost option but are not fully compliant with 21 CFR Part 11 or GCP, which can create regulatory risk for studies intended to support FDA or EMA submissions. Research teams need a platform that offers both flexibility and compliance while enabling rapid deployment. Capture.Study’s RWE data capture software addresses these challenges by combining speed, usability, and integrated functionality in a single solution.

When evaluating platforms for RWE studies, research teams should consider several critical factors:

1. Flexible Data Capture:
RWE studies involve diverse data sources, including EHRs, registries, and patient-reported outcomes. Choose a platform that allows seamless integration of multiple data types while maintaining data accuracy and consistency.

2. Integrated Features:
Managing RWE studies often requires more than just data collection. Look for platforms that combine EDC, ePRO, eConsent, randomization, and patient enrollment in one system to reduce administrative complexity.

3. Compliance:
Ensure that the platform supports 21 CFR Part 11, GCP, and GDPR compliance. Regulatory adherence is critical, even for observational studies, if the data will be used for decision-making or submissions.

4. Self-Serve Functionality:
RWE teams may not have access to a full IT or vendor support team. A self-serve system enables teams to set up and manage studies independently, avoiding delays and reducing operational costs.

5. Scalability:
The platform should scale from small registries to multi-site observational studies, enabling researchers to expand their RWE programs without migrating data or adding software.

Capture.Study provides a unified real-world evidence platform tailored to the needs of observational studies, registry research, and post-marketing surveillance. Its self-serve capabilities allow teams to upload study protocols and go live in under 10 minutes, eliminating months of setup required by traditional EDC systems.

The platform integrates all critical functions—EDC, ePRO, eConsent, enrollment, randomization, and IMP management—into a single interface. This unified approach reduces errors from manual data transfers and ensures consistency across sites and study types.

Regulatory compliance is built into the platform. Capture.Study adheres to 21 CFR Part 11, GCP, and GDPR, providing confidence that collected RWE data is reliable, auditable, and suitable for regulatory submissions.

The platform also offers transparent pricing with no setup fees, making it accessible for academic research teams, early-stage biotech companies, and post-marketing study sponsors. This eliminates financial barriers for small teams seeking to implement real-world evidence studies efficiently.

Rapid Study Launch: AI-assisted study build allows teams to go from protocol to live study in under 10 minutes. Forms, workflows, and data capture fields are automatically generated to match the study design.

Integrated Data Management: Capture.Study centralizes EHR integration, ePRO data, registry forms, and patient-reported outcomes in one system, minimizing data discrepancies and simplifying oversight.

Multi-Site Coordination: For large RWE studies spanning multiple clinical sites, Capture.Study ensures consistent study implementation, real-time monitoring, and secure data sharing.

Enhanced Data Quality: Built-in validation rules, real-time monitoring dashboards, and electronic patient-reported outcome tracking reduce errors and improve study reliability.

Scalability for Growth: The platform supports studies of varying sizes, from small investigator-initiated registries to multi-center post-marketing trials, enabling research teams to grow without switching platforms.

Plan Data Sources Early: Map all potential data streams and ensure the platform can integrate them seamlessly.

Leverage AI-Assisted Tools: Use AI-assisted study build to reduce manual setup time and improve accuracy.

Train Research Staff: Even self-serve platforms benefit from user training to maximize efficiency and ensure adherence to study protocols.

Monitor Data Continuously: Use dashboards to track enrollment, patient-reported outcomes, and data completeness in real time.

Consider Future Needs: Ensure the platform can handle expansions such as longitudinal studies, larger registries, or integration with other EDC systems.

Capture.Study is uniquely suited for research teams implementing RWE data capture software solutions. By combining rapid setup, integrated study components, regulatory compliance, and self-serve capabilities, the platform reduces operational burden while improving study quality. Teams can focus on data insights and outcomes rather than navigating complex legacy systems.

Whether running small observational studies, patient registries, or multi-site real-world evidence programs, Capture.Study provides a reliable, efficient, and compliant solution. Research teams can launch studies quickly, capture diverse data types accurately, and scale as their programs grow, making it the ideal real-world evidence platform.

For more information and to explore its features, visit capture.study.

Q: How quickly can RWE studies be launched using Capture.Study?
A: Studies can go live in under 10 minutes from protocol upload with AI-assisted study build.

Q: Is the platform compliant with regulatory standards?
A: Yes, it meets 21 CFR Part 11, GCP, and GDPR compliance requirements.

Q: Do I need a CRO or IT team to implement Capture.Study?
A: No, it’s fully self-serve and designed for teams without dedicated technical staff.

Q: Can the platform integrate ePRO and patient registry data?
A: Yes, all critical RWE components are integrated in one system.

A: No setup fees, transparent pricing, and a free trial are available.